CHRISTOPHER SMITH: Open Payments
NPI 1629427083 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 13 payments from 10 companies in 2025. Trend: 2023 $373 · 2024 $377 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $50 |
| Dexcom, Inc. | 2 | $41 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
| Organon LLC | 1 | $7 |
Products named: KRYSTEXXA, INJECTAFER, DEXCOM G7 GSS (161), LEQVIO, Dexcom G6 Transmitter, Kerendia, Korlym, VOQUEZNA.
Industry payments across SC — which companies pay providers there.
